News Sentiment

CELU sentiment intelligence

Celularity Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 47 Balanced news tone 58 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.74 Week of 10 Jul 2026
Weighted tone 47/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

84/100 classification confidence.

Company focus 50

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+19.5% over one week, +3.9% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Insider trust lends $1M to Celularity (NASDAQ: CELU) on short term

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 84/100 classification
One-week reaction 19.5% Price confirming higher
Trend fit Trend inactive 3.9% over four weeks
Fair value -69.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 3
Neutral 45
Negative 10

Relevance

Why the article matched

Direct first
Direct company coverage 50
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 16
Market source 8
TradingView 6
GlobeNewswire 5
marketscreener.com 3
simplywall.st 3
MT Newswires 2
Investing.com Nigeria 2

Event Lens

What the news is about

Classified themes
Market update 38
Earnings 10
Deals and strategy 5
Regulatory and legal 2
Balance sheet 2
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-58 of 58
Stock Titan Direct company coverage

Barach Family Trust (CELU) reports warrants and convertible notes in Celularity Form 3

The Philip & Daniele Barach Family Trust, a more than ten percent owner of Celularity Inc., has submitted a Form 3 filing detailing its existing holdings of warrants and convertible notes tied to Celularity’s Class A common stock. The filing clarifies that these are existing deri

Tone
Neutral 50/100
Event
Market update
Published
24 Apr 2026 23:10
Source
Stock Titan
Stock Titan Direct company coverage

Celularity Inc (CELU) insider Form 3 details warrants and convertible notes

A recently filed Form 3 reveals that Philip Alan Barach, through The Philip and Daniele Barach Family Trust, is a more than ten percent beneficial owner of Celularity Inc (CELU). The trust holds significant warrants and convertible notes, which can be converted into millions of s

Tone
Neutral 50/100
Event
Market update
Published
24 Apr 2026 22:38
Source
Stock Titan
Stock Titan Direct company coverage

Family trust reports 20.1% Celularity (CELU) stake from $10M financing

The Philip & Daniele Barach Family Trust has disclosed an amended ownership report on Celularity Inc. (CELU), revealing a beneficial ownership of 7,558,665 Class A common shares, which represents a 20.1% stake. This stake originates from a $10 million financing deal on December 1

Tone
Neutral 50/100
Event
Deals and strategy
Published
22 Apr 2026 14:10
Source
Stock Titan
www.marketscreener.com Direct company coverage

Nexgel Inc co and Celularity enter amendment no. 1 to license agreement on April 17, 2026

Nexgel Inc. and Celularity have executed Amendment No. 1 to their license agreement on April 17, 2026. This announcement by Reuters was published on April 21, 2026, at 06:27 pm EDT. The article also provides a company profile for Nexgel, Inc., detailing its focus on hydrogel prod

Tone
Neutral 50/100
Event
Market update
Published
22 Apr 2026 04:15
Source
www.marketscreener.com
Market source Direct company coverage

NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET

NEXGEL, Inc. has announced the rescheduling of its shareholder update conference call to April 21, 2026, at 4:30 P.M. ET, moving it up from April 23rd. The call will focus on the Celularity transaction and provide updates from the company, a leading provider of hydrogel-based hea

Tone
Neutral 50/100
Event
Market update
Published
21 Apr 2026 16:30
Source
Market source
Stock Titan Direct company coverage

Celularity (NASDAQ: CELU) closes NexGel asset sale as Helena note default looms

Celularity (NASDAQ: CELU) announced the closing of its NexGel asset sale, which generated $13.3 million in consideration and allowed the company to retire significant debt, enabling it to refocus on its core cell therapy platform. Concurrently, Celularity faces a looming default

Tone
Negative 40/100
Event
Balance sheet
Published
21 Apr 2026 13:08
Source
Stock Titan
Market source Direct company coverage

Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing

Celularity Inc. announced it received a notice from Nasdaq regarding its non-compliance with Listing Rule 5250(c)(1) for failing to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. The company has 60 calendar days to submit a plan to regain

Tone
Negative 34/100
Event
Market update
Published
17 Apr 2026 10:40
Source
Market source
Stock Titan Direct company coverage

Celularity (NASDAQ: CELU) CEO gains shares from RSU vesting

Celularity Inc. CEO Robert J. Hariri acquired 3,281 shares of Class A Common Stock from the vesting of Restricted Stock Units (RSUs) on April 13, 2026. This transaction represents 25% of an original 13,123-RSU award granted in 2022. To cover tax obligations, 1,182 shares were wit

Tone
Neutral 50/100
Event
Market update
Published
15 Apr 2026 20:40
Source
Stock Titan
Stock Titan Direct company coverage

RSU vesting lifts Celularity (CELU) insider holdings after tax withholding

Celularity Inc. executive Stephen Brigido reported the vesting of 821 restricted stock units (RSUs) on April 13, 2026, which converted into Class A Common Stock. To cover tax obligations, 268 shares were withheld at $1.28 per share, resulting in a net increase of 553 shares to hi

Tone
Neutral 50/100
Event
Market update
Published
15 Apr 2026 20:40
Source
Stock Titan
Stock Titan Direct company coverage

Celularity (NASDAQ: CELU) EVP RSUs vest into shares with tax withholding

Celularity Inc.'s Senior Executive Vice President, John R. Haines, had 1,641 restricted stock units (RSUs) vest and convert into Class A common stock. These RSUs were part of a larger grant from April 2022, with 25% vesting on April 13, 2026. To cover tax obligations, 583 shares

Tone
Neutral 50/100
Event
Market update
Published
15 Apr 2026 20:39
Source
Stock Titan
The Manila Times Direct company coverage

NEXGEL Reschedules Shareholder Update Conference Call to April 15th at 4:30 P.M. ET to Provide Update on Celularity Transaction

NEXGEL, Inc. has rescheduled its shareholder update conference call to April 15, 2026, at 4:30 P.M. ET to provide an update on the Celularity transaction. The company will not be financing the transaction under its previously announced Securities Purchase Agreement but is negotia

Tone
Neutral 50/100
Event
Market update
Published
08 Apr 2026 20:40
Source
The Manila Times
TradingView Direct company coverage

Barach Family Trust Secures Board Observer Role at Celularity with 9.56% Stake

The Philip & Daniele Barach Family Trust has disclosed a 9.56% stake in Celularity Inc.'s Class A common stock, encompassing convertible notes that could yield over 3 million shares. This investment grants the Trust a board observer role and the flexibility to influence strategic

Tone
Positive 63/100
Event
Deals and strategy
Published
03 Apr 2026 15:40
Source
TradingView